Michael E. Abram
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- HIV/AIDS drug development and treatment 18
- HIV/AIDS Research and Interventions 4
- Virology 13
- HIV Research and Treatment 13
- Co-authors
- Andrea L. Ferris (2 shared papers)Wei Shao (2 shared papers)Stephen H. Hughes (2 shared papers)W. Gregory Alvord (2 shared papers)Andrew Cheng (9 shared papers)Michael A. Parniak (3 shared papers)Marshall W. Fordyce (6 shared papers)Kirsten White (7 shared papers)
- Journals
- JAIDS Journal of Acquired Immune Deficiency Syndromes (7 papers)Journal of Virology (4 papers)HIV Clinical Trials (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)Molecular Pharmacology (2 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Michael E. Abram
34 papers receiving 1.5k citations
Michael E. Abram's Hit Papers
Peers
Comparison fields: 5 of 80
- Virology 531
- Infectious Diseases 967
- Emergency Medicine 198
- Epidemiology 393
- Hepatology 67
Countries citing papers authored by Michael E. Abram
This map shows the geographic impact of Michael E. Abram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Abram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Abram more than expected).
Fields of papers citing papers by Michael E. Abram
This network shows the impact of papers produced by Michael E. Abram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Abram. The network helps show where Michael E. Abram may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael E. Abram, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 197 | |
| 2 | 2015 | 160 | |
| 3 | 2016 | 128 | |
| 4 | 2007 | 109 | |
| 5 | 2013 | 101 | |
| 6 | 2013 | 99 | |
| 7 | Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants Hit paper breakdown → | 2023 | 78 |
| 8 | 2020 | 77 | |
| 9 | 2022 | 77 | |
| 10 | 2017 | 60 | |
| 11 | 2001 | 57 | |
| 12 | 2016 | 53 | |
| 13 | 2005 | 48 | |
| 14 | 2014 | 45 | |
| 15 | 2002 | 44 | |
| 16 | 2017 | 31 | |
| 17 | 1968 | 31 | |
| 18 | 2014 | 21 | |
| 19 | 2014 | 20 | |
| 20 | 2000 | 19 |
About Michael E. Abram
Michael E. Abram is a scholar working on Infectious Diseases, Virology, Molecular Biology, Epidemiology and Emergency Medicine, having authored 34 papers that have together received 1.6k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (13 papers), HIV-related health complications and treatments (4 papers), HIV/AIDS Research and Interventions (4 papers), Cancer therapeutics and mechanisms (3 papers), Respiratory viral infections research (3 papers), DNA and Nucleic Acid Chemistry (2 papers) and Congenital Diaphragmatic Hernia Studies (2 papers). The work is most often cited by research in Virology (531 citations), Infectious Diseases (967 citations), Emergency Medicine (198 citations), Epidemiology (393 citations) and Hepatology (67 citations). Michael E. Abram has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Andrea L. Ferris, Wei Shao, Stephen H. Hughes, W. Gregory Alvord, Andrew Cheng, Michael A. Parniak, Marshall W. Fordyce, Kirsten White, Edwin DeJesus and Ralf Wagner. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, Journal of Virology, HIV Clinical Trials, Antimicrobial Agents and Chemotherapy and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.